Victoria Vakiener
Chief Commercial Officer, Epizyme, Inc.
Companies
- Arrowhead PharmaceuticalsBoard member May 5, 2022 to now1
- Chimerix (United States)Board member Apr 26, 2021 to now2
- Epizyme, Inc.Chief Commercial Officer Sep 28, 2020 to Feb 5, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arrowhead Pharmaceuticals ARWR35,723 shares4$2.0M at $56.73Dec 19, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 19, 2025Sold 1,960 shares at $68.39 of Arrowhead Pharmaceuticals4
- Dec 19, 2025Sold 5,281 shares at $67.97 of Arrowhead Pharmaceuticals4
- Dec 19, 2025Sold 2,799 shares at $66.63 of Arrowhead Pharmaceuticals4
- Dec 16, 2025Granted 7,819 shares of Arrowhead Pharmaceuticals5
- Dec 18, 2024Granted 16,733 shares at $22.99 of Arrowhead Pharmaceuticals6
- Dec 16, 2024Sold 8,994 shares at $21.91 of Arrowhead Pharmaceuticals7
- May 2, 2024Sold 1,799 shares at $23.31 of Arrowhead Pharmaceuticals8
- Jan 11, 2024Sold 1,100 shares at $38.84 of Arrowhead Pharmaceuticals9
- Jan 11, 2024Sold 3,620 shares at $37.87 of Arrowhead Pharmaceuticals9
- Dec 15, 2023Granted 14,987 shares at $25.41 of Arrowhead Pharmaceuticals10
- Sep 28, 2023Sold 1,550 shares at $26.33 of Arrowhead Pharmaceuticals11
- Jan 10, 2023Granted 7,867 shares of Arrowhead Pharmaceuticals12
- Jan 10, 2023Returned to company 1,764 shares of Arrowhead Pharmaceuticals12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Dec 18, 2025
- 6SEC EDGARForm 4 filed Dec 20, 2024
- 7SEC EDGARForm 4 filed Dec 18, 2024
- 8SEC EDGARForm 4 filed May 6, 2024
- 9SEC EDGARForm 4 filed Jan 16, 2024
- 10SEC EDGARForm 4 filed Dec 19, 2023
- 11SEC EDGARForm 4 filed Oct 2, 2023
- 12SEC EDGARForm 4 filed Jan 11, 2023